Covered recipient · General Payments record
IAN CRESPO ORTA
Allopathic & Osteopathic Physicians General Practice
General Payments · PY2023–2024
$822.23
- Reported across 16 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $794.09 | 15 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Amgen Inc. | $225.45 | 2 |
| Adaptive Biotechnologies Corporation | $124.21 | 1 |
| Genmab U.S., Inc. | $109.86 | 1 |
| Tempus AI, Inc | $97.33 | 1 |
| Exelixis Inc. | $56.14 | 2 |
| ABBVIE INC. | $45.95 | 2 |
| PFIZER INC. | $42.28 | 2 |
| Janssen Pharmaceuticals, Inc | $36.75 | 2 |
| Takeda Pharmaceuticals U.S.A., Inc. | $33.33 | 1 |
| Biogen, Inc. | $22.79 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (15)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $20.95 | 08/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103514854 | CMS |
| ABBVIE INC. | $25.00 | 11/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103514856 | CMS |
| Adaptive Biotechnologies Corporation | $124.21 | 07/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150263335 | CMS |
| Amgen Inc. | $100.41 | 08/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111556133 | CMS |
| Amgen Inc. | $125.04 | 10/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111556131 | CMS |
| Biogen, Inc. | $22.79 | 10/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104862066 | CMS |
| Exelixis Inc. | $28.87 | 08/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1138558722 | CMS |
| Exelixis Inc. | $27.27 | 12/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1138558724 | CMS |
| Genmab U.S., Inc. | $109.86 | 05/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1126827250 | CMS |
| Janssen Pharmaceuticals, Inc | $19.47 | 08/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078169759 | CMS |
| Janssen Pharmaceuticals, Inc | $17.28 | 08/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078171649 | CMS |
| PFIZER INC. | $22.95 | 05/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131396355 | CMS |
| PFIZER INC. | $19.33 | 09/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131396032 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $33.33 | 05/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137520786 | CMS |
| Tempus AI, Inc | $97.33 | 07/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150163062 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2023, 2024
- Source files
- Dataset page · Bulk file · PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.